APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin Syringes

Insulin syringes are small-capacity syringe systems with graduations configured for a specified insulin concentration and commonly an integrated fine needle.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Unit graduations are tied to the specified concentration; they are not universal volume labels. Device comparison must retain that concentration and graduation relationship.

What turns activity into demand

Device demand is defined by container or delivery function, connection, materials and validated manufacturing. Prefilling adds formulation compatibility and storage integrity to the device boundary.

The commercial boundary

Injection, enteral, oral and analytical devices have different interfaces and intended uses. Representative images establish neither sterility nor clinical suitability.

Which concentration does the graduation scale assume?

Unit graduations are tied to the specified concentration; they are not universal volume labels. Device comparison must retain that concentration and graduation relationship.

Technical reading

Selected research

Market Outlook & Growth Opportunities

Global Insulin Syringes Market Outlook and Growth Opportunities 2026

22 December 2025203 pages

Choose your research edition.

Industry ResearchInsulin Syringes Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Syringes Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Insulin Syringes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Syringes Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Syringes Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Insulin Syringes market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Insulin Syringes market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Insulin Syringes market include Sanofi, Novo Nordisk, Eli Lilly and Company, Ypsomed AG, Wockhardt Ltd, Terumo Corporation, Nipro Medical Corporation, Medtronic Plc and Medline Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Insulin Syringes market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Insulin Syringes and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Insulin Syringes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Insulin Syringes market size, projected growth trends, production technologies, key applications, and end-use industries.

Insulin Syringes Segment by Company

Sanofi

Novo Nordisk

Eli Lilly and Company

Ypsomed AG

Wockhardt Ltd

Terumo Corporation

Nipro Medical Corporation

Medtronic Plc

Medline Industries

HMD Healthcare Ltd

F. Hoffmann-La Roche

Cardinal Health Inc

Braun Melunsun

Biocon Ltd

BD

Animas Corporation

Abbott Laboratories

Insulin Syringes Segment by Type

1/2 CC Syringe

1 CC Syringe

3/10 CC Syringe

Others

Insulin Syringes Segment by Application

Hospital

Homecare

Others

Insulin Syringes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Insulin Syringes status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Insulin Syringes market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Insulin Syringes significant trends, drivers, influence factors in global and regions.

6. To analyze Insulin Syringes competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Syringes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Syringes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Syringes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Insulin Syringes market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Insulin Syringes industry.

Chapter 3: Detailed analysis of Insulin Syringes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Insulin Syringes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Insulin Syringes in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Insulin Syringes Industry Trends Table 2. Insulin Syringes Industry Drivers Table 3. Insulin Syringes Industry Opportunities and Challenges Table 4. Insulin Syringes Industry Restraints Table 5. Global Insulin Syringes Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Insulin Syringes Revenue Share by Company (2021-2026) Table 7. Global Insulin Syringes Sales Volume by Company (k units) & (2021-2026) Table 8. Global Insulin Syringes Sales Volume Share by Company (2021-2026) Table 9. Global Insulin Syringes Average Price (US$/unit) of Company (2021-2026) Table 10. Global Insulin Syringes Company Ranking, (2024-2026) & (USD Million) Table 11. Global Insulin Syringes Key Company Manufacturing Base & Headquarters Table 12. Global Insulin Syringes Company, Product Type & Application Table 13. Global Insulin Syringes Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Insulin Syringes by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 1/2 CC Syringe Table 18. Significant Companies of 1 CC Syringe Table 19. Significant Companies of 3/10 CC Syringe Table 20. Significant Companies of Others Table 21. Global Insulin Syringes Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Insulin Syringes Sales Volume by Type (2021-2026) & (k units) Table 23. Global Insulin Syringes Sales Volume by Type (2027-2032) & (k units) Table 24. Global Insulin Syringes Sales Volume Share by Type (2021-2026) Table 25. Global Insulin Syringes Sales Volume Share by Type (2027-2032) Table 26. Global Insulin Syringes Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Insulin Syringes Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Insulin Syringes Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Insulin Syringes Sales Value Share by Type (2021-2026) Table 30. Global Insulin Syringes Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Homecare Table 33. Significant Companies of Others Table 34. Global Insulin Syringes Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Insulin Syringes Sales Volume by Application (2021-2026) & (k units) Table 36. Global Insulin Syringes Sales Volume by Application (2027-2032) & (k units) Table 37. Global Insulin Syringes Sales Volume Share by Application (2021-2026) Table 38. Global Insulin Syringes Sales Volume Share by Application (2027-2032) Table 39. Global Insulin Syringes Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Insulin Syringes Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Insulin Syringes Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Insulin Syringes Sales Value Share by Application (2021-2026) Table 43. Global Insulin Syringes Sales Value Share by Application (2027-2032) Table 44. Global Insulin Syringes Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Insulin Syringes Sales by Region (2021-2026) & (k units) Table 46. Global Insulin Syringes Sales Market Share by Region (2021-2026) Table 47. Global Insulin Syringes Sales by Region (2027-2032) & (k units) Table 48. Global Insulin Syringes Sales Market Share by Region (2027-2032) Table 49. Global Insulin Syringes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Insulin Syringes Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Insulin Syringes Sales Value Share by Region (2021-2026) Table 52. Global Insulin Syringes Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Insulin Syringes Sales Value Share by Region (2027-2032) Table 54. Global Insulin Syringes Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global Insulin Syringes Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global Insulin Syringes Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Insulin Syringes Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Insulin Syringes Sales by Country (2021-2026) & (k units) Table 59. Global Insulin Syringes Sales Market Share by Country (2021-2026) Table 60. Global Insulin Syringes Sales by Country (2027-2032) & (k units) Table 61. Global Insulin Syringes Sales Market Share by Country (2027-2032) Table 62. Global Insulin Syringes Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Insulin Syringes Sales Value Market Share by Country (2021-2026) Table 64. Global Insulin Syringes Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Insulin Syringes Sales Value Market Share by Country (2027-2032) Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Sanofi Insulin Syringes Product Portfolio Table 70. Sanofi Recent Development Table 71. Novo Nordisk Company Information Table 72. Novo Nordisk Business Overview Table 73. Novo Nordisk Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Novo Nordisk Insulin Syringes Product Portfolio Table 75. Novo Nordisk Recent Development Table 76. Eli Lilly and Company Company Information Table 77. Eli Lilly and Company Business Overview Table 78. Eli Lilly and Company Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Eli Lilly and Company Insulin Syringes Product Portfolio Table 80. Eli Lilly and Company Recent Development Table 81. Ypsomed AG Company Information Table 82. Ypsomed AG Business Overview Table 83. Ypsomed AG Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Ypsomed AG Insulin Syringes Product Portfolio Table 85. Ypsomed AG Recent Development Table 86. Wockhardt Ltd Company Information Table 87. Wockhardt Ltd Business Overview Table 88. Wockhardt Ltd Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Wockhardt Ltd Insulin Syringes Product Portfolio Table 90. Wockhardt Ltd Recent Development Table 91. Terumo Corporation Company Information Table 92. Terumo Corporation Business Overview Table 93. Terumo Corporation Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Terumo Corporation Insulin Syringes Product Portfolio Table 95. Terumo Corporation Recent Development Table 96. Nipro Medical Corporation Company Information Table 97. Nipro Medical Corporation Business Overview Table 98. Nipro Medical Corporation Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Nipro Medical Corporation Insulin Syringes Product Portfolio Table 100. Nipro Medical Corporation Recent Development Table 101. Medtronic Plc Company Information Table 102. Medtronic Plc Business Overview Table 103. Medtronic Plc Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Medtronic Plc Insulin Syringes Product Portfolio Table 105. Medtronic Plc Recent Development Table 106. Medline Industries Company Information Table 107. Medline Industries Business Overview Table 108. Medline Industries Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Medline Industries Insulin Syringes Product Portfolio Table 110. Medline Industries Recent Development Table 111. HMD Healthcare Ltd Company Information Table 112. HMD Healthcare Ltd Business Overview Table 113. HMD Healthcare Ltd Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. HMD Healthcare Ltd Insulin Syringes Product Portfolio Table 115. HMD Healthcare Ltd Recent Development Table 116. F. Hoffmann-La Roche Company Information Table 117. F. Hoffmann-La Roche Business Overview Table 118. F. Hoffmann-La Roche Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. F. Hoffmann-La Roche Insulin Syringes Product Portfolio Table 120. F. Hoffmann-La Roche Recent Development Table 121. Cardinal Health Inc Company Information Table 122. Cardinal Health Inc Business Overview Table 123. Cardinal Health Inc Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Cardinal Health Inc Insulin Syringes Product Portfolio Table 125. Cardinal Health Inc Recent Development Table 126. Braun Melunsun Company Information Table 127. Braun Melunsun Business Overview Table 128. Braun Melunsun Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Braun Melunsun Insulin Syringes Product Portfolio Table 130. Braun Melunsun Recent Development Table 131. Biocon Ltd Company Information Table 132. Biocon Ltd Business Overview Table 133. Biocon Ltd Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Biocon Ltd Insulin Syringes Product Portfolio Table 135. Biocon Ltd Recent Development Table 136. BD Company Information Table 137. BD Business Overview Table 138. BD Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. BD Insulin Syringes Product Portfolio Table 140. BD Recent Development Table 141. Animas Corporation Company Information Table 142. Animas Corporation Business Overview Table 143. Animas Corporation Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Animas Corporation Insulin Syringes Product Portfolio Table 145. Animas Corporation Recent Development Table 146. Abbott Laboratories Company Information Table 147. Abbott Laboratories Business Overview Table 148. Abbott Laboratories Insulin Syringes Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Abbott Laboratories Insulin Syringes Product Portfolio Table 150. Abbott Laboratories Recent Development Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Insulin Syringes Distributors List Table 154. Insulin Syringes Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Insulin Syringes Product Image Figure 2. Global Insulin Syringes Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Syringes Sales Value (2021-2032) & (US$ Million) Figure 4. Global Insulin Syringes Sales (2021-2032) & (k units) Figure 5. Global Insulin Syringes Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Insulin Syringes Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1/2 CC Syringe Image Figure 10. 1 CC Syringe Image Figure 11. 3/10 CC Syringe Image Figure 12. Others Image Figure 13. Global Insulin Syringes Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Insulin Syringes Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Insulin Syringes Sales Volume Share by Type (2021-2032) Figure 16. Global Insulin Syringes Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Insulin Syringes Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Insulin Syringes Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Homecare Image Figure 21. Others Image Figure 22. Global Insulin Syringes Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Insulin Syringes Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Insulin Syringes Sales Volume Share by Application (2021-2032) Figure 25. Global Insulin Syringes Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Insulin Syringes Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Insulin Syringes Sales Value Share by Application (2021-2032) Figure 28. Global Insulin Syringes Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Insulin Syringes Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Insulin Syringes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Insulin Syringes Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Insulin Syringes Sales Value (2021-2032) & (US$ Million) Figure 33. North America Insulin Syringes Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Insulin Syringes Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Insulin Syringes Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Insulin Syringes Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Insulin Syringes Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Insulin Syringes Sales Value (2021-2032) & (US$ Million) Figure 39. South America Insulin Syringes Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Insulin Syringes Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Insulin Syringes Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Insulin Syringes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Insulin Syringes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Insulin Syringes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Insulin Syringes Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Insulin Syringes Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 1/2 CC Syringe
  • 1 CC Syringe
  • 3/10 CC Syringe
  • Others
Applications
  • Hospital
  • Homecare
  • Others
Companies covered
  • Sanofi
  • Novo Nordisk
  • Eli Lilly and Company
  • Ypsomed AG
  • Wockhardt Ltd
  • Terumo Corporation
  • Nipro Medical Corporation
  • Medtronic Plc
  • Medline Industries
  • HMD Healthcare Ltd
  • F. Hoffmann-La Roche
  • Cardinal Health Inc
  • Braun Melunsun
  • Biocon Ltd
  • BD
  • Animas Corporation
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin Syringes Sales Value (2021-2032)
  4. 1.2.2 Global Insulin Syringes Sales Volume (2021-2032)
  5. 1.2.3 Global Insulin Syringes Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Insulin Syringes Market Dynamics
  1. 2.1 Insulin Syringes Industry Trends
  2. 2.2 Insulin Syringes Industry Drivers
  3. 2.3 Insulin Syringes Industry Opportunities and Challenges
  4. 2.4 Insulin Syringes Industry Restraints
3 Insulin Syringes Market by Company
  1. 3.1 Global Insulin Syringes Company Revenue Ranking in 2025
  2. 3.2 Global Insulin Syringes Revenue by Company (2021-2026)
  3. 3.3 Global Insulin Syringes Sales Volume by Company (2021-2026)
  4. 3.4 Global Insulin Syringes Average Price by Company (2021-2026)
  5. 3.5 Global Insulin Syringes Company Ranking (2024-2026)
  6. 3.6 Global Insulin Syringes Company Manufacturing Base and Headquarters
  7. 3.7 Global Insulin Syringes Company Product Type and Application
  8. 3.8 Global Insulin Syringes Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Insulin Syringes Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Insulin Syringes Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Insulin Syringes Market by Type
  1. 4.1 Insulin Syringes Type Introduction
  2. 4.1.1 1/2 CC Syringe
  3. 4.1.2 1 CC Syringe
  4. 4.1.3 3/10 CC Syringe
  5. 4.1.4 Others
  6. 4.2 Global Insulin Syringes Sales Volume by Type
  7. 4.2.1 Global Insulin Syringes Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Insulin Syringes Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Insulin Syringes Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Insulin Syringes Sales Value by Type
  11. 4.3.1 Global Insulin Syringes Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Insulin Syringes Sales Value by Type (2021-2032)
  13. 4.3.3 Global Insulin Syringes Sales Value Share by Type (2021-2032)
5 Insulin Syringes Market by Application
  1. 5.1 Insulin Syringes Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Homecare
  4. 5.1.3 Others
  5. 5.2 Global Insulin Syringes Sales Volume by Application
  6. 5.2.1 Global Insulin Syringes Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Insulin Syringes Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Insulin Syringes Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Insulin Syringes Sales Value by Application
  10. 5.3.1 Global Insulin Syringes Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Insulin Syringes Sales Value by Application (2021-2032)
  12. 5.3.3 Global Insulin Syringes Sales Value Share by Application (2021-2032)
6 Insulin Syringes Regional Sales and Value Analysis
  1. 6.1 Global Insulin Syringes Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Insulin Syringes Sales by Region (2021-2032)
  3. 6.2.1 Global Insulin Syringes Sales by Region: 2021-2026
  4. 6.2.2 Global Insulin Syringes Sales by Region (2027-2032)
  5. 6.3 Global Insulin Syringes Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Insulin Syringes Sales Value by Region (2021-2032)
  7. 6.4.1 Global Insulin Syringes Sales Value by Region: 2021-2026
  8. 6.4.2 Global Insulin Syringes Sales Value by Region (2027-2032)
  9. 6.5 Global Insulin Syringes Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Insulin Syringes Sales Value (2021-2032)
  12. 6.6.2 North America Insulin Syringes Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Insulin Syringes Sales Value (2021-2032)
  15. 6.7.2 Europe Insulin Syringes Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Insulin Syringes Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Insulin Syringes Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Insulin Syringes Sales Value (2021-2032)
  21. 6.9.2 South America Insulin Syringes Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Insulin Syringes Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Insulin Syringes Sales Value Share by Country, 2025 VS 2032
7 Insulin Syringes Country-level Sales and Value Analysis
  1. 7.1 Global Insulin Syringes Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Insulin Syringes Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Insulin Syringes Sales by Country (2021-2032)
  4. 7.3.1 Global Insulin Syringes Sales by Country (2021-2026)
  5. 7.3.2 Global Insulin Syringes Sales by Country (2027-2032)
  6. 7.4 Global Insulin Syringes Sales Value by Country (2021-2032)
  7. 7.4.1 Global Insulin Syringes Sales Value by Country (2021-2026)
  8. 7.4.2 Global Insulin Syringes Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Insulin Syringes Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Insulin Syringes Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Insulin Syringes Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Insulin Syringes Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Insulin Syringes Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Insulin Syringes Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Insulin Syringes Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Insulin Syringes Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Insulin Syringes Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Insulin Syringes Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Insulin Syringes Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Insulin Syringes Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Insulin Syringes Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Insulin Syringes Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Insulin Syringes Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Insulin Syringes Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Insulin Syringes Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Insulin Syringes Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Insulin Syringes Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Insulin Syringes Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Insulin Syringes Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Insulin Syringes Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Insulin Syringes Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Insulin Syringes Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Insulin Syringes Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Insulin Syringes Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Insulin Syringes Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Insulin Syringes Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Insulin Syringes Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Insulin Syringes Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Insulin Syringes Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Insulin Syringes Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Novo Nordisk
  8. 8.2.1 Novo Nordisk Company Information
  9. 8.2.2 Novo Nordisk Business Overview
  10. 8.2.3 Novo Nordisk Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novo Nordisk Insulin Syringes Product Portfolio
  12. 8.2.5 Novo Nordisk Recent Developments
  13. 8.3 Eli Lilly and Company
  14. 8.3.1 Eli Lilly and Company Company Information
  15. 8.3.2 Eli Lilly and Company Business Overview
  16. 8.3.3 Eli Lilly and Company Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly and Company Insulin Syringes Product Portfolio
  18. 8.3.5 Eli Lilly and Company Recent Developments
  19. 8.4 Ypsomed AG
  20. 8.4.1 Ypsomed AG Company Information
  21. 8.4.2 Ypsomed AG Business Overview
  22. 8.4.3 Ypsomed AG Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ypsomed AG Insulin Syringes Product Portfolio
  24. 8.4.5 Ypsomed AG Recent Developments
  25. 8.5 Wockhardt Ltd
  26. 8.5.1 Wockhardt Ltd Company Information
  27. 8.5.2 Wockhardt Ltd Business Overview
  28. 8.5.3 Wockhardt Ltd Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Wockhardt Ltd Insulin Syringes Product Portfolio
  30. 8.5.5 Wockhardt Ltd Recent Developments
  31. 8.6 Terumo Corporation
  32. 8.6.1 Terumo Corporation Company Information
  33. 8.6.2 Terumo Corporation Business Overview
  34. 8.6.3 Terumo Corporation Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Terumo Corporation Insulin Syringes Product Portfolio
  36. 8.6.5 Terumo Corporation Recent Developments
  37. 8.7 Nipro Medical Corporation
  38. 8.7.1 Nipro Medical Corporation Company Information
  39. 8.7.2 Nipro Medical Corporation Business Overview
  40. 8.7.3 Nipro Medical Corporation Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nipro Medical Corporation Insulin Syringes Product Portfolio
  42. 8.7.5 Nipro Medical Corporation Recent Developments
  43. 8.8 Medtronic Plc
  44. 8.8.1 Medtronic Plc Company Information
  45. 8.8.2 Medtronic Plc Business Overview
  46. 8.8.3 Medtronic Plc Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Medtronic Plc Insulin Syringes Product Portfolio
  48. 8.8.5 Medtronic Plc Recent Developments
  49. 8.9 Medline Industries
  50. 8.9.1 Medline Industries Company Information
  51. 8.9.2 Medline Industries Business Overview
  52. 8.9.3 Medline Industries Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Medline Industries Insulin Syringes Product Portfolio
  54. 8.9.5 Medline Industries Recent Developments
  55. 8.10 HMD Healthcare Ltd
  56. 8.10.1 HMD Healthcare Ltd Company Information
  57. 8.10.2 HMD Healthcare Ltd Business Overview
  58. 8.10.3 HMD Healthcare Ltd Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 HMD Healthcare Ltd Insulin Syringes Product Portfolio
  60. 8.10.5 HMD Healthcare Ltd Recent Developments
  61. 8.11 F. Hoffmann-La Roche
  62. 8.11.1 F. Hoffmann-La Roche Company Information
  63. 8.11.2 F. Hoffmann-La Roche Business Overview
  64. 8.11.3 F. Hoffmann-La Roche Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 F. Hoffmann-La Roche Insulin Syringes Product Portfolio
  66. 8.11.5 F. Hoffmann-La Roche Recent Developments
  67. 8.12 Cardinal Health Inc
  68. 8.12.1 Cardinal Health Inc Company Information
  69. 8.12.2 Cardinal Health Inc Business Overview
  70. 8.12.3 Cardinal Health Inc Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Cardinal Health Inc Insulin Syringes Product Portfolio
  72. 8.12.5 Cardinal Health Inc Recent Developments
  73. 8.13 Braun Melunsun
  74. 8.13.1 Braun Melunsun Company Information
  75. 8.13.2 Braun Melunsun Business Overview
  76. 8.13.3 Braun Melunsun Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Braun Melunsun Insulin Syringes Product Portfolio
  78. 8.13.5 Braun Melunsun Recent Developments
  79. 8.14 Biocon Ltd
  80. 8.14.1 Biocon Ltd Company Information
  81. 8.14.2 Biocon Ltd Business Overview
  82. 8.14.3 Biocon Ltd Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Biocon Ltd Insulin Syringes Product Portfolio
  84. 8.14.5 Biocon Ltd Recent Developments
  85. 8.15 BD
  86. 8.15.1 BD Company Information
  87. 8.15.2 BD Business Overview
  88. 8.15.3 BD Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 BD Insulin Syringes Product Portfolio
  90. 8.15.5 BD Recent Developments
  91. 8.16 Animas Corporation
  92. 8.16.1 Animas Corporation Company Information
  93. 8.16.2 Animas Corporation Business Overview
  94. 8.16.3 Animas Corporation Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Animas Corporation Insulin Syringes Product Portfolio
  96. 8.16.5 Animas Corporation Recent Developments
  97. 8.17 Abbott Laboratories
  98. 8.17.1 Abbott Laboratories Company Information
  99. 8.17.2 Abbott Laboratories Business Overview
  100. 8.17.3 Abbott Laboratories Insulin Syringes Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Abbott Laboratories Insulin Syringes Product Portfolio
  102. 8.17.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Insulin Syringes Value Chain Analysis
  2. 9.1.1 Insulin Syringes Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Insulin Syringes Sales Mode & Process
  6. 9.2 Insulin Syringes Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Insulin Syringes Distributors
  9. 9.2.3 Insulin Syringes Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst